• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

31.52 -0.38 (-1.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,057,079
Open 31.58
Bid (Size) 31.20 (100)
Ask (Size) 32.00 (200)
Prev. Close 31.90
Today's Range 30.93 - 32.10
52wk Range 4.300 - 40.37
Shares Outstanding 45,711,975
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Capricor Therapeutics Q1 Earnings Call Highlights ↗
Today 18:08 EDT
Capricor Therapeutics (NASDAQ:CAPR) said its Duchenne muscular dystrophy therapy candidate deramiocel remains under active FDA review, while the company is preparing to commercialize the product itself... 
Via MarketBeat
Topics Earnings
Capricor Therapeutics Inc (NASDAQ:CAPR) Q1 Results Show EPS Miss as Market Awaits August PDUFA Date ↗
Today 16:43 EDT
Via Chartmill

Performance

YTD
+11.3%
+11.3%
1 Month
-8.7%
-8.7%
3 Month
+28.0%
+28.0%
6 Month
+408.4%
+408.4%
1 Year
+343.3%
+343.3%

More News

Read More
News headline image
Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story ↗
May 10, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval ↗
March 13, 2026
Via Stocktwits
Topics Earnings
Capricor Therapeutics Inc (NASDAQ:CAPR) Reports Q4 2025 Loss, Focus Remains on FDA Review for Deramiocel ↗
March 12, 2026
Via Chartmill
News headline image
CAPR Stock Heads For Best Week In Nearly A Month: CEO Says 'No Way' Deramiocel Gets Only Conditional Approval ↗
March 13, 2026
Via Stocktwits
Topics Earnings
News headline image
Capricor (CAPR) Q4 2025 Earnings Call Transcript ↗
March 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Capricor Reports Wider Quarterly Loss Than Expected But All Eyes Are On Muscle Disease Therapy ↗
March 12, 2026
Via Stocktwits
News headline image
Capricor Therapeutics’ DMD Treatment Study Shows Improvement In Key Heart Function Measures ↗
March 12, 2026
Via Stocktwits
News headline image
CAPR Stock Surged 17% Today — What’s Fueling The Rally? ↗
March 10, 2026
Via Stocktwits
News headline image
CAPR Stock In Spotlight As Investors Eye Next Week’s DMD Trial Data Showing Muscle And Cardiac Gains ↗
March 05, 2026
Via Stocktwits
News headline image
Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? ↗
February 23, 2026
Via Stocktwits
News headline image
Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
February 23, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs Government
News headline image
CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗
February 20, 2026
Via Stocktwits
News headline image
CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗
January 20, 2026
Via Stocktwits
News headline image
Here's Why This Biotechnology Skyrocketed by 439% in December ↗
January 09, 2026
Via The Motley Fool
News headline image
On Friday, there are stocks with unusual volume. Let's take a look. ↗
December 05, 2025
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
December 04, 2025
Via Chartmill
News headline image
Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire ↗
December 04, 2025
Via Stocktwits
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
Via MarketMinute
News headline image
‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win ↗
December 03, 2025
Via Stocktwits
News headline image
Why Did Capricor Therapeutics Stock Skyrocket Today? ↗
December 03, 2025
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
December 03, 2025
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Point To Steady Open: Why CAPR, MRVL, AEO, GTLB, CRWD Are On Traders' Radar ↗
December 03, 2025
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
News headline image
Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout ↗
December 01, 2025
Via Stocktwits

Frequently Asked Questions

Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
What is the current price of Capricor Therapeutics, Inc. - Common Stock?
The current price of Capricor Therapeutics, Inc. - Common Stock is 31.52
When was Capricor Therapeutics, Inc. - Common Stock last traded?
The last trade of Capricor Therapeutics, Inc. - Common Stock was at 05/12/26 04:00 PM ET
What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 1.44B
How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
Capricor Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap